Free hepatitis C, HIV and syphilis testing for the month of December
“Southeastern Idaho Public Health will be offering free rapid hepatitis C, HIV and syphilis testing to individuals throughout the month of December in all their county locations. Testing only takes a few minutes, and you can get results before you leave. Visit siphidaho.org to locate a clinic near you. Same-day appointments are available. There is only one way to know — get tested.”
Atea plans Phase 3 study for hepatitis C drug after mid-stage results
“In the Phase 2 study, patients received a combination of bemnifosbuvir and ruzasvir for eight weeks, without any reports of serious side effects or treatment discontinuations. Twelve weeks later, researchers measured the effects the drugs had in fighting hepatitis C. Overall, 98% of patients who adhered to the treatment regimen had a sustained virologic response at the 12-week checkpoint. That rate went up to 99% among patients who weren’t suffering from cirrhosis. And Atea said the drugs showed success even among patients who didn’t take all the pills as directed, suggesting a “robust potency” for the treatment.””
Priorities in planning person-centred hepatitis B and C testing services: operational guide
“This operational guide on viral hepatitis testing services provides support to countries in developing policies and practices that define a strategic mix of hepatitis B and C testing approaches, that are tailored to their unique situation and priorities, ensuring an impactful national response to the hepatitis epidemic. It introduces a five-step framework for planning person-centred hepatitis B and C testing approaches, emphasizing a strategic mix of testing approaches, mobilization and demand creation, and streamlined linkage to care. It highlights as well the importance of community leadership, health systems integration and quality assurance.”
Broadly effective vaccine design offers new hope in the fight against hepatitis C
‘The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due to the high genetic diversity of the virus. A research team has now achieved promising results. Using epitope-focused immunogens, they were able to induce broadly neutralizing antibodies (bnAbs) in laboratory models for the first time.”
Hepatitis C and Homelessness: Assessing Risk Factors
“A study conducted in Madrid, Spain, found a high prevalence of HCV among people experiencing homelessness. Of the 2,709 PEH screened, 47.4% of those with HCV antibodies tested positive for active HCV (HCV-RNA).”
